Steve Curtis
InvestorManaging Director, Director of New Ventures at BrightEdge
About
Steve Curtis is Director of New Ventures at BrightEdge, the impact venture capital arm of the ACS. He previously managed MPM Capital's Oncology Innovations Fund, a venture/philanthropy collaboration with Dana-Farber Cancer Institute, where he invested in seed and Series A biotech companies. Earlier roles include Senior Director of Business Development at Eli Lilly, co-leading the Bioscience Ventures group at 2M Companies, and running technology in-licensing at Reata Pharmaceuticals.
Invests in
BiotechImpact & Social Good
Frequently asked questions
- Where does Steve Curtis work?
- Steve Curtis is Managing Director, Director of New Ventures at BrightEdge.
- What does Steve Curtis invest in?
- Steve Curtis invests in Biotech, Impact & Social Good.
